New Animal Drugs for Use in Animal Feeds; Monensin

Samenvatting

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA provides for revised labeling for the use of single-ingredient monensin Type A medicated articles to make Type C medicated feeds used for the prevention and control of coccidiosis in feedlot cattle. The regulations are being amended to remove a redundant entry for use of monensin in Type C medicated cattle feeds.